Phase I study of ursodeoxycholic acid in combination with 5-fluorouracil, leucovorin, oxaliplatin, and bevacizumab for metastatic colorectal cancer

被引：0
|
作者：
Lai, Lily L.
Chiu, Ken
Lim, Dean
Chao, Joseph
Frankel, Paul Henry
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Hope Canc Ctr, Beckman Res Inst, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
569
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer
    Rocha, Jose Aurillo
    ANTI-CANCER DRUGS, 2011, 22 : S9 - S13
  • [22] A Phase II study of ANGIOZYME® in combination with 5-fluorouracil, leucovorin and irinotecan in the treatment of metastatic colorectal cancer patients
    Usman, N
    Venook, A
    Hurwitz, H
    Cunningham, C
    Fuchs, C
    Burris, H
    Schwartzberg, L
    Pelley, R
    Miller, WH
    Modiano, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S72 - S72
  • [23] Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer
    Said, Rabih
    Ye, Yang
    Hong, David S.
    Naing, Aung
    Falchook, Gerald
    Fu, Siqing
    Wheler, Jennifer J.
    Piha-Paul, Sarina
    Tsimberidou, Apostolia-Maria
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (03) : 575 - 581
  • [24] Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer
    Rabih Said
    Yang Ye
    David S. Hong
    Aung Naing
    Gerald Falchook
    Siqing Fu
    Jennifer J. Wheler
    Sarina Piha-Paul
    Apostolia-Maria Tsimberidou
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 575 - 581
  • [25] Oxaliplatin/5-Fluorouracil/Leucovorin in Colorectal Cancer With Malignant Ascites, an Observational Study
    Lee, S.
    Lee, D. H.
    Oh, S. Y.
    Kwon, H. C.
    Kim, S. H.
    Lee, J. H.
    Lee, Y. L.
    Huh, S. J.
    Yoon, H. H.
    Kim, H. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S418 - S419
  • [26] Phase I Study of Cediranib in Combination with Oxaliplatin and Infusional 5-Fluorouracil in Patients with Advanced Colorectal Cancer
    Chen, Eric
    Jonker, Derek
    Gauthier, Isabelle
    MacLean, Martha
    Wells, Julie
    Powers, Jean
    Seymour, Lesley
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1481 - 1486
  • [27] A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial
    Tabernero, Josep
    Yoshino, Takayuki
    Stintzing, Sebastian
    de Gramont, Aimery
    Gibbs, Peter
    Jonker, Derek J.
    Nygren, Peter
    Papadimitriou, Christos
    Prager, Gerald W.
    Tell, Roger
    Lenz, Heinz-Josef
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (01): : 28 - 37
  • [28] Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer
    van Zuylen, L
    Bridgewater, J
    Sparreboom, A
    Eskens, FALM
    de Bruijn, P
    Sklenar, I
    Planting, AST
    Choi, L
    Bootle, D
    Mueller, C
    Ledermann, JA
    Verweij, J
    CLINICAL CANCER RESEARCH, 2004, 10 (06) : 1949 - 1955
  • [29] Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer
    Recchia, F
    Rea, S
    Nuzzo, A
    Lalli, A
    Di Lullo, L
    De Filippis, S
    Saggio, G
    Biondi, E
    Massa, E
    Mantovani, G
    ANTICANCER RESEARCH, 2004, 24 (3B) : 1935 - 1940
  • [30] Dose intensity of oxaliplatin in 5-fluorouracil and leucovorin regimens in pretreated metastatic colorectal cancer.
    Jeong, KJ
    Oh, JM
    Choi, SK
    Oh, D
    PHARMACOTHERAPY, 2002, 22 (10): : 1356 - 1356
12345